Glucose-regulated Protein 58 Modulates β-catenin Protein Stability in a Cervical Adenocarcinoma Cell Line

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2014 Aug 2

PMID 25081282

Citations 4

Authors

Chia-Jung Liao

Tzu-I Wu

Ya-Hui Huang

Ting-Chang Chang

Chyong-Huey Lai

Shih-Ming Jung

Chuen Hsueh

Kwang-Huei Lin

Affiliations

Soon will be listed here.

Abstract

Background: Cervical cancer continues to threaten women's health worldwide, and the incidence of cervical adenocarcinoma (AD) is rising in the developed countries. Previously, we showed that glucose-regulated protein 58 (Grp58) served as an independent factor predictive of poor prognosis of patients with cervical AD. However, the molecular mechanism underlying the involvement of Grp58 in cervical carcinogenesis is currently unknown.

Methods: DNA microarray and enrichment analysis were used to identify the pathways disrupted by knockdown of Grp58 expression.

Results: Among the pathway identified, the WNT signaling pathway was one of those that were significantly associated with knockdown of Grp58 expression in HeLa cells. Our experiments showed that β-catenin, a critical effector of WNT signaling, was stabilized thereby accumulated in stable Grp58 knockdown cells. Membrane localization of β-catenin was observed in Grp58 knockdown, but not control cells. Using a transwell assay, we found that accumulated β-catenin induced by Grp58 knockdown or lithium chloride treatment inhibited the migration ability of HeLa cells. Furthermore, an inverse expression pattern of Grp58 and β-catenin was observed in cervical tissues.

Conclusions: Our results demonstrate that β-catenin stability is negatively regulated by Grp58 in HeLa cells. Overexpression of Grp58 may be responsible for the loss of or decrease in membranous β-catenin expression in cervical AD.

Citing Articles

Insights into the role of ERp57 in cancer.

Song D, Liu H, Wu J, Gao X, Hao J, Fan D J Cancer. 2021; 12(8):2456-2464.

PMID: 33758622 PMC: 7974888. DOI: 10.7150/jca.48707.

Expression of protein disulfide isomerase A3 precursor in colorectal cancer.

Yang Z, Liu J, Shi Q, Chao Y, Di Y, Sun J Onco Targets Ther. 2018; 11:4159-4166.

PMID: 30050307 PMC: 6056171. DOI: 10.2147/OTT.S154452.

Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Hettinghouse A, Liu R, Liu C Pharmacol Ther. 2017; 181:34-48.

PMID: 28723413 PMC: 5743601. DOI: 10.1016/j.pharmthera.2017.07.011.

Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.

Zhu Y, Cai L, Guo J, Chen N, Yi X, Zhao Y Tumour Biol. 2016; 37(10):14009-14023.

PMID: 27492604 DOI: 10.1007/s13277-016-5218-4.

References

Cromme F, van Bommel P, Walboomers J, Gallee M, Stern P, Kenemans P . Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Cancer. 1994; 69(6):1176-81. PMC: 1969430. DOI: 10.1038/bjc.1994.231. View

Hovanes K, Li T, Munguia J, Truong T, Milovanovic T, Marsh J . Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet. 2001; 28(1):53-7. DOI: 10.1038/ng0501-53. View

Gien L, Beauchemin M, Thomas G . Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2009; 116(1):140-6. DOI: 10.1016/j.ygyno.2009.09.040. View

Hagen T, Sethi J, Foxwell N, Vidal-Puig A . Signalling activity of beta-catenin targeted to different subcellular compartments. Biochem J. 2004; 379(Pt 2):471-7. PMC: 1224088. DOI: 10.1042/BJ20031749. View

Pedrinaci S, Algarra I, Garcia Lora A, Gaforio J, Perez M, Garrido F . Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma. Int J Clin Lab Res. 2000; 29(4):166-73. DOI: 10.1007/s005990050085. View

Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T . L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 2005; 168(4):633-42. PMC: 2171754. DOI: 10.1083/jcb.200408051. View

Hirano N, Shibasaki F, Sakai R, Tanaka T, Nishida J, Yazaki Y . Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase. Identification of its secretory form and inducible expression by the oncogenic transformation. Eur J Biochem. 1995; 234(1):336-42. DOI: 10.1111/j.1432-1033.1995.336_c.x. View

Jaitner S, Reiche J, Schaffauer A, Hiendlmeyer E, Herbst H, Brabletz T . Human telomerase reverse transcriptase (hTERT) is a target gene of β-catenin in human colorectal tumors. Cell Cycle. 2012; 11(17):3331-8. PMC: 3466531. DOI: 10.4161/cc.21790. View

Ganesan K, Ivanova T, Wu Y, Rajasegaran V, Wu J, Lee M . Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Res. 2008; 68(11):4277-86. DOI: 10.1158/0008-5472.CAN-07-6517. View

10.

Altieri F, Maras B, Eufemi M, Ferraro A, TURANO C . Purification of a 57kDa nuclear matrix protein associated with thiol:protein-disulfide oxidoreductase and phospholipase C activities. Biochem Biophys Res Commun. 1993; 194(3):992-1000. DOI: 10.1006/bbrc.1993.1919. View

11.

Morrice N, Powis S . A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr Biol. 1998; 8(12):713-6. DOI: 10.1016/s0960-9822(98)70279-9. View

12.

Imura J, Ichikawa K, Takeda J, Fujimori T . Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma. Int J Mol Med. 2001; 8(4):353-8. View

13.

Rodriguez-Sastre M, Gonzalez-Maya L, Delgado R, Lizano M, Tsubaki G, Mohar A . Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol Oncol. 2005; 97(2):330-6. DOI: 10.1016/j.ygyno.2004.12.062. View

14.

Ouellet V, Le Page C, Guyot M, Lussier C, Tonin P, Provencher D . SET complex in serous epithelial ovarian cancer. Int J Cancer. 2006; 119(9):2119-26. DOI: 10.1002/ijc.22054. View

15.

Wu S, Huang Y, Yeh C, Tsai M, Liao C, Cheng W . Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells. Oncogene. 2011; 30(17):2057-69. DOI: 10.1038/onc.2010.585. View

16.

Fadare O, Reddy H, Wang J, Hileeto D, Schwartz P, Zheng W . E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases. World J Surg Oncol. 2005; 3:38. PMC: 1183253. DOI: 10.1186/1477-7819-3-38. View

17.

Hildesheim A, Berrington de Gonzalez A . Etiology and prevention of cervical adenocarcinomas. J Natl Cancer Inst. 2006; 98(5):292-3. DOI: 10.1093/jnci/djj098. View

18.

Corazzari M, Lovat P, Armstrong J, Fimia G, Hill D, Birch-Machin M . Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: the role of stress proteins ERdj5 and ERp57. Br J Cancer. 2007; 96(7):1062-71. PMC: 2360126. DOI: 10.1038/sj.bjc.6603672. View

19.

Angers S, Moon R . Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol. 2009; 10(7):468-77. DOI: 10.1038/nrm2717. View

20.

Frickel E, Frei P, Bouvier M, Stafford W, Helenius A, Glockshuber R . ERp57 is a multifunctional thiol-disulfide oxidoreductase. J Biol Chem. 2004; 279(18):18277-87. DOI: 10.1074/jbc.M314089200. View